Phospholipase A2 structure/function, mechanism, and signaling

Funk, 2001, Prostaglandins and leukotrienes: advances in eicosanoid biology, Science., 294, 1871, 10.1126/science.294.5548.1871

Rivera, 2008, Biological effects of lysophospholipids, Rev. Physiol. Biochem. Pharmacol., 160, 25

Stephens, 1898, The action of cobra poison on the blood: a contribution to the study of passive immunity, J. Pathol. Bacteriol., 5, 279, 10.1002/path.1700050307

Seilhamer, 1989, Cloning and recombinant expression of phospholipase A2 present in rheumatoid arthritic synovial fluid, J. Biol. Chem., 264, 5335, 10.1016/S0021-9258(18)83549-9

Kramer, 1989, Structure and properties of a human non-pancreatic phospholipase A2, J. Biol. Chem., 264, 5768, 10.1016/S0021-9258(18)83616-X

Kuchler, 1989, Analysis of the Cdna for phospholipase-A2 from honeybee venom glands - the deduced amino-acid sequence reveals homology to the corresponding vertebrate enzymes, Eur. J. Biochem., 184, 249, 10.1111/j.1432-1033.1989.tb15014.x

Clark, 1991, A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP, Cell., 65, 1043, 10.1016/0092-8674(91)90556-E

Kramer, 1991, The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells, J. Biol. Chem., 266, 5268, 10.1016/S0021-9258(19)67782-3

Dennis, 1994, Diversity of group types, regulation, and function of phospholipase A2, J. Biol. Chem., 269, 13057, 10.1016/S0021-9258(17)36794-7

Chen, 1994, Cloning and recombinant expression of a novel human low-molecular-weight Ca2+-dependent phospholipase-a(2), J. Biol. Chem., 269, 2365, 10.1016/S0021-9258(17)41952-1

Balboa, 1996, Novel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophages, J. Biol. Chem., 271, 32381, 10.1074/jbc.271.50.32381

Ackermann, 1994, Ca(2+)-independent cytosolic phospholipase A2 from macrophage-like P388D1 cells. Isolation and characterization, J. Biol. Chem., 269, 9227, 10.1016/S0021-9258(17)37098-9

Six, 2000, The expanding superfamily of phospholipase A(2) enzymes: classification and characterization, Biochim. Biophys. Acta., 1488, 1, 10.1016/S1388-1981(00)00105-0

Schaloske, 2006, The phospholipase A2 superfamily and its group numbering system, Biochim. Biophys. Acta., 1761, 1246, 10.1016/j.bbalip.2006.07.011

Scott, 1990, Interfacial catalysis: the mechanism of phospholipase A2, Science., 250, 1541, 10.1126/science.2274785

Yu, 1991, Critical role of a hydrogen bond in the interaction of phospholipase A2 with transition-state and substrate analogues, Proc. Natl. Acad. Sci. USA., 88, 9325, 10.1073/pnas.88.20.9325

Gelb, 1995, Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2, Annu. Rev. Biochem., 64, 653, 10.1146/annurev.bi.64.070195.003253

Carman, 1995, Lipid signaling enzymes and surface dilution kinetics, J. Biol. Chem., 270, 18711, 10.1074/jbc.270.32.18711

Plesniak, 1995, Conformation of micellar phospholipid bound to the active site of phospholipase A2, Biochemistry., 34, 4943, 10.1021/bi00015a005

Burke, 2008, Interaction of group IA phospholipase A2 with metal ions and phospholipid vesicles probed with deuterium exchange mass spectrometry, Biochemistry., 47, 6451, 10.1021/bi8000962

Lin, 1998, Docking phospholipase A2 on membranes using electrostatic potential-modulated spin relaxation magnetic resonance, Science., 279, 1925, 10.1126/science.279.5358.1925

Singer, 2002, Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2, J. Biol. Chem., 277, 48535, 10.1074/jbc.M205855200

Lambeau, 2008, Biochemistry and physiology of mammalian secreted phospholipases A2, Annu. Rev. Biochem., 77, 495, 10.1146/annurev.biochem.76.062405.154007

Schevitz, 1995, Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2, Nat. Struct. Biol., 2, 458, 10.1038/nsb0695-458

Lambeau, 1999, Receptors for a growing family of secreted phospholipases A2, Trends Pharmacol. Sci., 20, 162, 10.1016/S0165-6147(99)01300-0

Saegusa, 2008, Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins {alpha}v{beta}3 and {alpha}4{beta}1 and induces proliferation of monocytic cells in an integrin-dependent manner, J. Biol. Chem., 283, 26107, 10.1074/jbc.M804835200

Kramer, 1986, Solubilization and properties of Ca2+-dependent human platelet phospholipase A2, Biochim. Biophys. Acta., 878, 394, 10.1016/0005-2760(86)90248-1

Ghosh, 2006, Properties of the group IV phospholipase A2 family, Prog. Lipid Res., 45, 487, 10.1016/j.plipres.2006.05.003

Reynolds, 1993, Metal ion and salt effects on the phospholipase A2, lysophospholipase, and transacylase activities of human cytosolic phospholipase A2, Biochim. Biophys. Acta., 1167, 272, 10.1016/0005-2760(93)90229-3

Bonventre, 1997, Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2, Nature., 390, 622, 10.1038/37635

Uozumi, 1997, Role of cytosolic phospholipase A2 in allergic response and parturition, Nature., 390, 618, 10.1038/37622

Uozumi, 2002, Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice, Prostaglandins Other Lipid Mediat., 68–69, 59, 10.1016/S0090-6980(02)00021-7

Dessen, 1999, Crystal structure of human cytosolic phospholipase A2 reveals a novel topology and catalytic mechanism, Cell., 97, 349, 10.1016/S0092-8674(00)80744-8

Hsu, 2008, Calcium binding rigidifies the C2 domain and the intra-domain interaction of GIVA phospholipase A2 as revealed by hydrogen/deuterium exchange mass spectrometry, J. Biol. Chem., 283, 9820, 10.1074/jbc.M708143200

Burke, 2008, A phospholipid substrate molecule residing in the membrane surface mediates opening of the lid region in group IVA cytosolic phospholipase A2, J. Biol Chem, 283, 31227, 10.1074/jbc.M804492200

Stahelin, 2007, Ceramide-1-phosphate binds group IVA cytosolic phospholipase a2 via a novel site in the C2 domain, J. Biol. Chem., 282, 20467, 10.1074/jbc.M701396200

Six, 2003, Essential Ca(2+)-independent role of the group IVA cytosolic phospholipase A(2) C2 domain for interfacial activity, J. Biol. Chem., 278, 23842, 10.1074/jbc.M301386200

Burke, 2008, Phospholipase A2 biochemistry, Cardiovasc. Drugs Ther.

Six, 2007, Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A(2) and group v secreted phospholipase A(2), J. Med. Chem., 50, 4222, 10.1021/jm0613673

McKew, 2008, Indole cytosolic phospholipase A2 alpha inhibitors: discovery and in vitro and in vivo characterization of 4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(dipheny lmethyl)-1H-indol-3-yl]propyl}benzoic acid, efipladib, J. Med. Chem., 51, 3388, 10.1021/jm701467e

Yaksh, 2006, Systemic and intrathecal effects of a novel series of phospholipase A(2) inhibitors on hyperalgesia and spinal prostaglandin E-2 release, J. Pharmacol. Exp. Ther., 316, 466, 10.1124/jpet.105.091686

Adler, 2008, Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction, J. Clin. Invest., 118, 2121

Balboa, 1997, Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells, J. Biol. Chem., 272, 8576, 10.1074/jbc.272.13.8576

Winstead, 2000, Calcium-independent phospholipase A(2): structure and function, Biochim. Biophys. Acta., 1488, 28, 10.1016/S1388-1981(00)00107-4

Song, 2006, A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols, Biochemistry., 45, 1061, 10.1021/bi052065q

Balsinde, 2005, Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A(2) in activated cells, Cell. Signal., 17, 1052, 10.1016/j.cellsig.2005.03.002

Bao, 2004, Male mice that do not express group VIA phospholipase A2 produce spermatozoa with impaired motility and have greatly reduced fertility, J. Biol. Chem., 279, 38194, 10.1074/jbc.M406489200

Bao, 2006, Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis, J. Biol. Chem., 281, 20958, 10.1074/jbc.M600075200

Bao, 2007, Attenuated free cholesterol loading-induced apoptosis but preserved phospholipid composition of peritoneal macrophages from mice that do not express group VIA phospholipase A2, J. Biol. Chem., 282, 27100, 10.1074/jbc.M701316200

Ramanadham, 2008, Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice, Am. J. Pathol., 172, 868, 10.2353/ajpath.2008.070756

Baskakis, 2008, Synthesis of polyfluoro ketones for selective inhibition of human phospholipase A2 enzymes, J. Med. Chem., 51, 8027, 10.1021/jm800649q

Lopez-Vales, R., X. Navarro, T. Shimizu, C. Baskakis, G. Kokotos, V. Constantinou-Kokotou, D. Stephens, E. A. Dennis, and S. David. 2008. Intracellular phospholipase A2 group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain.

Mishra, 2008, iPLA2beta: front and center in human monocyte chemotaxis to MCP-1, J. Exp. Med., 205, 347, 10.1084/jem.20071243

Gelb, 2000, Do membrane-bound enzymes access their substrates from the membrane or aqueous phase: interfacial versus non-interfacial enzymes, Biochim. Biophys. Acta., 1488, 20, 10.1016/S1388-1981(00)00106-2

Tjoelker, 1995, Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad, J. Biol. Chem., 270, 25481, 10.1074/jbc.270.43.25481

Gardner, 2008, Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein, J. Biol. Chem., 283, 17099, 10.1074/jbc.M802394200

Tjoelker, 1995, Anti-inflammatory properties of a platelet-activating factor acetylhydrolase, Nature., 374, 549, 10.1038/374549a0

Lavi, 2008, Role of lipoprotein-associated phospholipase A2 in atherosclerosis, Curr. Atheroscler. Rep., 10, 230, 10.1007/s11883-008-0036-9

Lerman, 2008, Lipoprotein-associated phospholipase A2: a risk marker or a risk factor?, Am. J. Cardiol., 101, 11F, 10.1016/j.amjcard.2008.04.014

Blackie, 2003, The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2, Bioorg. Med. Chem. Lett., 13, 1067, 10.1016/S0960-894X(03)00058-1

Serruys, 2008, Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque, Circulation., 118, 1172, 10.1161/CIRCULATIONAHA.108.771899

Mohler, 2008, J. Am. Coll. Cardiol., 51, 1632, 10.1016/j.jacc.2007.11.079

Wilensky, 2008, Inhibition of lipoprotein-associated phospholipase A(2) reduces complex coronary atherosclerotic plaque development, Nat. Med., 10.1038/nm.1870